NCT01506544View on ClinicalTrials.gov

Pharmacokinetics (PK) of Liquid Hydroxyurea in Pediatric Patients With Sickle Cell Anemia

PHASE1CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

December 31, 2013

Study Completion Date

January 31, 2014

Conditions
Sickle Cell Anemia
Interventions
DRUG

Hydroxyurea

20mg/kg of Hydroxyurea or the patient's standard daily dose

Trial Locations (6)

10032

Columbia University Medical Center, New York

27710

Duke University Medical Center, Durham

35233

Children's Hospital of Alabama, Birmingham

53226

Children's Hospital of Wisconsin, Wauwatosa

60614-3363

Children's Memorial Hospital (Northwestern University), Chicago

75390-9063

UT Southwestern University Hospital, Dallas

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Children's Mercy Hospital Kansas City

OTHER

NCT01506544 - Pharmacokinetics (PK) of Liquid Hydroxyurea in Pediatric Patients With Sickle Cell Anemia | Biotech Hunter | Biotech Hunter